Importantly, the ENZ-activated Jak2-Stat5 pathway promoted the growth of PC cells during ENZ treatment and, at the same time, inhibition of Stat5 as a second-line treatment induced extensive death of PC cells surviving ENZ treatment. This evidence concerns the gene STAT5B and pachyonychia congenita.